Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subarachnoid Hemorrhage.

K D Flemming1, R D Brown, D O Wiebers

  • 1Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Current Treatment Options in Neurology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and radiologic distinctions between familial cavernous malformation syndrome and cerebral amyloid angiopathy.

Acta neurochirurgica·2024
Same author

Tobacco use increases lesion burden in familial cerebral cavernous malformation syndrome.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2024
Same author

Baseline and Evolutionary Radiologic Features in Sporadic, Hemorrhagic Brain Cavernous Malformations.

AJNR. American journal of neuroradiology·2019
Same author

Clinical and Imaging Characteristics of Diffuse Intracranial Dolichoectasia.

AJNR. American journal of neuroradiology·2017
Same author

Distinguishing clinical and radiological features of non-traumatic convexal subarachnoid hemorrhage.

European journal of neurology·2016
Same author

Update on stroke risk factors.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Subarachnoid hemorrhage requires intensive care unit admission for monitoring and prompt neurosurgical consultation. Early aneurysm management and vasospasm prevention are crucial for improving patient outcomes and reducing mortality.

Area of Science:

  • Neurology
  • Neurosurgery
  • Critical Care Medicine

Background:

  • Subarachnoid hemorrhage (SAH) is a critical condition with high mortality rates.
  • Effective management involves close monitoring, prevention of rebleeding, and medical complications.

Purpose of the Study:

  • To outline essential management strategies for patients with subarachnoid hemorrhage.
  • To emphasize timely interventions for aneurysm treatment and vasospasm prevention.

Main Methods:

  • Admission to the intensive care unit for neurologic and cardiorespiratory monitoring.
  • Neurosurgical consultation for procedures like external ventricular drain placement and arteriography.
  • Implementation of seizure prophylaxis, antihypertensive treatment, pain control, and DVT/GI prophylaxis.

Related Experiment Videos

Main Results:

  • Early arteriography and definitive aneurysm management are recommended for good-grade SAH patients.
  • Treatment decisions for aneurysms consider aneurysm characteristics and patient condition.
  • Postoperative surveillance for vasospasm using clinical examination and transcranial Doppler ultrasonography.

Conclusions:

  • Aggressive management, including intensive monitoring and timely intervention, is vital for SAH patients.
  • Prevention and treatment of rebleeding and vasospasm are key to improving survival and reducing morbidity.
  • A multimodal approach combining medical and surgical/interventional strategies optimizes patient care.